QuickBird Medical
  • Case Studies
    • Case Studies
    • Customers
  • Services
    • Development: DiGA
    • Development: Medical Software
    • Development: Health Apps
    • Development: Wearables for Medical Devices
    • Development: Decision Support Systems
    • Development: Medical AI Systems
    • Legal Manufacturer for Medical Devices
    • BSI TR-03161 for DiGA
    • ePA & Health ID for DiGA
    • Support for your Software Team
    • Further Services
  • Insights
  • Team
  • Jobs
  • Contact
  • German
Select Page
Guide to §374a SGB V – Interoperability for DiGA, aids & implants

Guide to §374a SGB V – Interoperability for DiGA, aids & implants

by Alexander Fenkiw | May 3, 2022 | diga-whitepaper, Unkategorisiert

Attention manufacturers of electronic aids, implants and DiGA! From mid-2024, a new legal requirement will apply to improve interoperability between medical devices and digital health applications (DiGA) approved by the BfArM: §374a SGB V Specifically, this involves...
DiGA: Guidelines for demonstrating positive supply effects

DiGA: Guidelines for demonstrating positive supply effects

by Alexander Fenkiw | Jun 18, 2021 | diga-whitepaper, Unkategorisiert

 What is the point of a DiGA if it does not improve patients’ lives? There is none! This is why DiGAs are only justified when their positive supply effect has been proven. Only then do you have a chance of being permanently included in the BfArM register....
Guide to the DiGAV: Digital Health Applications Ordinance

Guide to the DiGAV: Digital Health Applications Ordinance

by Malte Bucksch | Mar 31, 2020 | diga-whitepaper, Unkategorisiert

The Digital Supply Act came into force on December 19, 2019. One of the biggest changes: Digital health applications (DiGA) can now be reimbursed by statutory health insurance companies if they meet certain requirements. To do this, the manufacturer of the healthcare...
Next Entries »

Insider-Empfehlungen für DiGA-Hersteller in 2025
Downloaden Sie jetzt unser Whitepaper

Insider-Empfehlungen für Software-Medizinprodukt-Hersteller in 2025
Downloaden Sie jetzt unser Whitepaper


Sie planen eine Medical Software oder DiGA?

Sprechen Sie mit unserem Geschäftsführer Malte Bucksch

+49 (0) 89 54998380
kontakt@quickbirdmedical.com

Are you planning to develop medical software or a digital health application?

Speak with our founder, Malte Bucksch

+49 (0) 89 54998380
kontakt@quickbirdmedical.com
Kontakt

+49 (0) 89 54998380
kontakt@quickbirdmedical.com

 

Whitepaper

13 wichtige Empfehlungen für angehende DiGA-Hersteller 2025

13 wichtige Empfehlungen für angehende Medizinprodukt-Hersteller 2025

Aktuelles

DiGA- und Medical Software-Newsletter

Digital Health Events 2025

Presse – QuickBird in den Medien

© 2025 Impressum | Datenschutz